VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1823835
Sex: M
Age:
State: MA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Localized soreness at injection site after about 6 hours progressed to generalized aches, fatigue, and headache in 24 hours. Resolved in 48 hours.; aches; fatigue; headache; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiration date was not reported), via an unspecified route of administration, administered in right arm on 01Mar2021 09:15am (at the age of 38-years-old) as dose 2, single for covid-19 immunization at workplace clinic. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiration date was not reported), via an unspecified route of administration, administered in right arm on 10Feb2021 10:00 am (at the age of 38-years-old) as dose 1, single for covid-19 immunization at workplace clinic. The patient does not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications were received by the patient within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 01Mar2021 the patient experienced localized soreness at injection site after about 6 hours at 03:15 pm progressed to generalized aches, fatigue, and headache in 24 hours. No treatment was received for the adverse events. Resolved in 48 hours. The outcome of the events was recovered on 03Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823836
Sex: M
Age:
State: NY

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Just typical injection site pain and fatigue; Just typical injection site pain and fatigue; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 53-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in left arm on 02Mar2021 09:00 AM (Lot number: EL3247, at the age of 53-year-old) as dose 1, single dose for COVID-19 immunization. The patient's medical history was not reported. No COVID prior to vaccination. No other vaccine administered in four weeks. The patient's concomitant medications in two weeks included secukinumab (COSENTYX) taken for an unspecified indication, start and stop date were not reported. On 02Mar2021 12:00 PM, the patient experienced just typical injection site pain and fatigue. Patient not tested for COVID post vaccination. No treatment received for the events. The outcome of the event was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: COSENTYX.

Current Illness:

ID: 1823837
Sex: F
Age:
State: MI

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 28-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE; formulation: solution for injection, Batch/Lot number: EL3248), dose 1 via an unspecified route of administration, administered in left arm on 01Mar2021 at 12:15 hours as dose 1, single (at the age of 28-years-old) for COVID-19 immunisation. The patient's medical history included anxiety. Concomitant medications included sertraline hydrochloride (ZOLOFT) received within 2 weeks of vaccination. The patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Mar2021, the patient experienced diarrhea. The event was reported as non-serious and did not result in death/life threatening/caused/prolonged hospitalization/congenital anomaly/birth defect. The patient received no treatment for the adverse event. The patient confirmed that the date the patient experienced the reported event was on 01Mar2021 and reported the information on 03Mar2021. The clinical outcome for the event was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT.

Current Illness:

ID: 1823838
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Caller got sick after receiving the 1st dose; This is a spontaneous report from a Pfizer-sponsored program Pfizer Support. This is a spontaneous report from a contactable consumer (female) reported for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. On an unspecified date the patient experienced caller got sick after receiving the 1st dose. Patient wanted to be rescheduled since her second dose will be tomorrow. The outcome of the event was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823839
Sex: U
Age:
State: FL

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; little sore arm; Dizziness; balance problems; the balance is getting worse; This is a spontaneous report from a contactable consumer (Patient) or other non-HCP. A 73-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unspecified route of administration, on 23Feb2021 (Lot number was not reported, age at the time of vaccination was 73-year-old) as a dose 2, single for COVID-19 immunization. The relevant medical history included pacemaker, blood cholesterol and thyroid from an unspecified date. Concomitant medications included levothyroxine 0.05 mg, one before going to breakfast, taken for thyroid and terazosin hydrochloride (HYTRIN) 10mg, at night before going to sleep, taken for an unspecified indication. Previously, the patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via unspecified route of administration, on an unspecified date, as dose 1, single for COVID-19 immunization. On 23Feb2021 at 19:00, the patient experienced headache, little sore arm, dizziness, balance problems and the balance is getting worse. Consumer stated that he/she had the COVID about 4 months ago and was in the hospital for 9 days. He/she took our first shot 90 days later that and took our second shot on Tuesday, had every reaction mentioned on the paper; every side effect plus had one that was not going away which was balance problems and headache. Patient had a little sore arm, but the main thing was balance problem and feel like was falling over. He/she stated that the start date of experiencing the events was after taking the shot on Tuesday (23Feb2021). The problem started about 7 o clock in the night on 23Feb2021. When probed for the route of administration, stated upper arm into the muscle. Other medical conditions and concomitant medications included high blood pressure, had a pacemaker and took medication for cholesterol, things like that, took for his/her thyroid, took for his/her urinary something like that, took 20 different medications. When probed about still experiencing the event, he/she stated yes (not further clarified which events consumer was still experiencing). When probed about whether the event worsened improved or still persisting, patient stated the balance was getting worse, it came on later than other problems it has been last 3-4 days, it came on that night after the shot and had no muscle coordination and dizziness. When probed whether patient took any treatment for the events, he/she stated no. Patient took Tylenol. dose of Tylenol, stated 3 tablets, regular tablets every 6 hours and stopped it yesterday. Patient asked that how do find out this was the effect of shot. The clinical outcome of events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; HYTRIN

Current Illness:

ID: 1823840
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Chills; slept all day the day after dose; This is a spontaneous report from a contactable consumer. This consumer reported for a 73-Year-old female patient that who received bnt162b2 (BNT162B2) solution for injection, dose 2 (Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (at the age of 73-years-old) as dose 1 single for covid-19 immunisation. Medical history included Crohn's disease from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Chills and slept all day the day after dose (but no fever), age: 73, date of birth: provided, slept all day the day after dose. Outcome of the events was unknown. Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823841
Sex: M
Age:
State:

Vax Date:
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202102; Test Name: INR; Result Unstructured Data: Test Result:high; Test Name: INR; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: INR was high; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable male consumer (patient) reported that: A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 16Jan2021 as dose 1, single and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. Medical history included heart problems and takes coumadin/ not clarified if patient had heart problems before or after covid vaccine. Concomitant medication was not reported. On 16Jan2021 patient received dose 1 of COVID-19 vaccine and week and half later tested and INR was high (Feb2021). HCP told to skip a pill. Again received dose 2 of COVID-19 vaccine and again tested with INR was high. The patient underwent lab tests and procedures which included international normalised ratio: high on Feb2021 and high on an unspecified date. The outcome of the event was unknown. Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823842
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: sore arm in shot location (both shots); headache (first shot); This is a spontaneous report from a contactable consumer (patient). A 75-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, patient had her 2nd COVID-19 dose and had no symptoms of any kind except for sore arm in shot location (both shots) and a headache (first shot) reported on an unspecified date. But she believed it was due to high pressure front coming into their area. She stated that she would like to be part of your 3rd dose COVID-19 vaccine trials if possible. The outcome of both the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823843
Sex: F
Age:
State: LA

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Sore arm in shot location (both shots); This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A female patient of an unspecified age (Age: 75, Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Unknown) via intramuscular route of administration on 13Feb2021 as dose 2, single for COVID-19 immunization. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and experienced sore arm in shot location and headache. The patient medical history and concomitant medications were not reported. The patient experienced sore arm in shot location on an unspecified date in 2021. Patient would like to be part of 3rd dose Covid19 vaccine trials if possible. The clinical outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823844
Sex: M
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: stomach upset; Nausea.; Cold sweats; Chills; This is a spontaneous report from a contactable consumer received via Pfizer sponsored program Support. A male patient (consumer's son) of an unspecified age received bnt162b2 (Pfizer Covid 19 Vaccine, Formulation: Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced stomach upset, nausea, cold sweats and chills. Outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1823846
Sex: F
Age:
State: MI

Vax Date: 02/24/2021
Onset Date: 02/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Dizzy; Little headache; I was little tired; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route, administered in left arm (upper left arm like the shoulder area) on 24Feb2021 (at the age of 58 years) as Dose 2, Single for Covid-19 immunization. There were no medical history and concomitant medications reported. On 27Feb2021, the patient experienced dizzy, little headache, and was little tired. Patient got second vaccine (later clarified as COVID 19 Vaccine) on Wednesday which was the 24Feb2021 and felt great. Everything went great, and patient was little tired. But yesterday she started getting very dizzy and was dizzy today. Reporter stated, she mean she didn't have fever, no chills, her arm really wasn't sore, it's just all that it's dizzy, and like a little headache. So, the patient wasn't really sure if that was normal. She got her card, and she would have to put her glasses on as she could not see very well. Reporter added, "she just took a Motrin and Benadryl today (clarified as treatment)". No investigation assessment was reported. The patient received Motrin and Benadryl as a treatment medication for resulted events. The outcome of dizzy was not recovered and the outcome of other events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823847
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Muscle soreness in the upper left arm; Lethargy the next day.; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received bnt162b2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration, administered Left arm on 05Feb2021 at 02:00 PM (at the age of 33-year-old) as dose 1 and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration, administered Left arm on 26Feb2021 02:00 PM (at the age of 33-year-old) as dose 2, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included Allergic to morphine, sulpha drugs. The patient's other medications within 2 weeks of vaccination included etonogestrel (NEXPLANON). The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for Covid-19. New information (04Mar2021): included this is a follow up-spontaneous report from a contactable consumer. This consumer reported in response to consumer letter sent via e-mail which included that she provided a response to the first email, she received this morning. she was aware of the adverse event on 26Feb2021, as stated in her report. On 27Feb2021, they received a report from patient that you experienced some adverse events after the 2nd dose COVID-19 vaccine. In the report it stated the event onset date was on 26Feb2021 Muscle soreness in the upper left arm and Lethargy the next day. The patient did not receive any treatment for the events. The oucome of events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: NEXPLANON

Current Illness:

ID: 1823848
Sex: F
Age:
State: NJ

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: sore arm; fatigue/tiredness; severe chills; headache; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported for a female patient that: A female patient of an unspecified age (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), via an unspecified route of administration on Feb2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient experienced sore arm, fatigue, tiredness, severe chills and headache on Feb2021. Acetaminophen and ibuprofen were taken as a treatment. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. On an unspecified date in 2021, the outcome of the events were recovered. Lot/Batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823849
Sex: M
Age:
State: IN

Vax Date: 02/23/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: pain when I was walking, in my left heel again, one of my feet; the bottom of my feet was giving me problem 10 20 seconds it was throbbing and if I walk too much it hurts me; my nose is running you know runny nose; nose is like a cold; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162b2 (Pfizer-BioNTech COVID-19 m RNA Vaccine, Solution for injection, Batch/Lot Number: EN6201; Expiration Date: Jun2021, NDC and UPC number was unknown), via an unspecified route of administration, administered in left arm on 23Feb2021 as dose 2, single (at the age of 71-year-old) for COVID-19 immunisation. Medical history included blood pressure (not sure, it was 10 years ago) and prediabetic from unknown to unknown of ongoing. Concomitant medications included linagliptin (Trajenta) and amlodipine, olmesartan for blood pressure. Historical vaccine included patient received BNT162b2 (Pfizer-BioNTech COVID-19 m RNA Vaccine, Solution for injection, Batch/Lot Number: EL8982 and Expiration Date: May2021, NDC and UPC number was unknown), via an unspecified route of administration, administered in left arm on 26Jan2021 as dose 1, single (at the age of 71-year-old) for COVID-19 immunisation and had a little pain on bottom of his feet of heel for days. On 23Feb2021, when patient came home at night, patient had pain when he was walking, in his left heel again, pain in one of his feet/left feet at the bottom of the feet on the heel and last night when patient was sitting the bottom of his feet was giving him problem 10-20 seconds it was throbbing. Patient stated that had pain and when he was talking, he still has pain but that much pain unbearable, also when he was walking had had pain at the bottom of his feet. On Feb2021, after couple of days his nose was running beside that patient did not have anything else, but his nose was like a cold. Patient did not receive any treatment for the events. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds: TRAJENTA; AMLODIPINE;OLMESARTAN

Current Illness:

ID: 1823850
Sex: F
Age:
State: CT

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Strong pain in her muscles; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Feb2021 (lot number and expiry date: unknown) as dose 1, single, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced strong pain in her muscles on an unspecified date in 2021. The outcome of the event was unknown. No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1823851
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: she started feeling uncomfortable symptoms; feeling really sick; pains in the neck and back; pains in the neck and back; palpitations; stomach upset; stiffness; dizziness; chills; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program Support. A female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unknown date, the patient experienced started feeling uncomfortable symptoms like, feeling really sick, pains in the neck and back, palpitations, stomach upset, stiffness, dizziness and chills. The outcome of all events was unknown. Follow-up attempts were completed. No further information was expected.

Other Meds:

Current Illness:

ID: 1823852
Sex: F
Age:
State: IL

Vax Date:
Onset Date: 02/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This is a spontaneous report from a contactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced not feeling well and dizziness on Feb 25, 2021. The patient due to get her 2nd dose of COVID-19 vaccine today on Feb 25, 2021. But when she woke up she was not feeling well; she was experiencing dizziness. Now she wants to reschedule her appointment because she will not be able to make it. The outcome of the events: unknown. No follow-up attempts needed. No further information expected. Information about batch/lot cannot be obtained.

Other Meds:

Current Illness:

ID: 1823853
Sex: F
Age:
State: TN

Vax Date: 02/04/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: ill and not feeling well; ill and not feeling well; bad eye pain; This is a spontaneous report from a Pfizer Sponsored Program Support via a contactable consumer reported for a patient (Mother). A 85-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 04Feb2021 (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient was ill and not feeling well and experienced bad eye pain. The patient was scheduled for the 2nd dose on 25Feb2021 (exactly 21 days apart). The caller claimed that the patient was unable to make it that day and wanted to reschedule her 2nd dose since the patient was currently ill and not feeling well. The caller asked to reschedule the patient's vaccination schedule that day since the patient experienced bad eye pain. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1823854
Sex: M
Age:
State: TN

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: dizziness; arm pain; This is a spontaneous report from a contactable consumer (wife) or other non-health care professional. A 87-year-old male patient received First dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection, Batch/Lot Number: FL9261) via an unspecified route of administration on 26Jan2021 at the age of 87-year-old as dose 1, single for covid-19 immunization. Medical history included has a pacemaker, Takes heart pills, Takes three pills a day, sick, and Flu. Concomitant therapy mentioned as yes. Family history was none, No relevant tests. No Prior vaccinations within 4 weeks. Last year when they both got home, they were really sick. Both caller and her husband, had to go to the Emergency room. Were sick for 3-4 weeks. Believes they had the COVID virus. Can't say for sure if it was COVID, but was told they both had the Flu. Caller mentioned this to the doctor and some say she and her husband might have had the COVID virus. Confirmed this was a year ago, prior to receiving the COVID vaccines. On an unspecified date the patient experienced dizziness, arm pain. Outcome of the events were unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1823855
Sex: F
Age:
State: LA

Vax Date:
Onset Date: 02/24/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Name: Blood sugar; Result Unstructured Data: Test Result: increased.

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: sugar level increased; This is a spontaneous report from a Pfizer sponsored program Support from a contactable female consumer (patient). A female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced that her sugar level increased on 24Feb2021 after the vaccine. Patient was inquiring if it is normal to have that side effect and how long it will last. The outcome of the event was unknown. Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823856
Sex: M
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: felt faint; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sales representative. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 24Feb2021 as dose 1, single for covid-19 immunisation. Medical history included AFIB (atrial fibrillation) on an unknown date, complex cardiac history from an unknown date and recent hospitalization on an unknown date. The patient's concomitant medications were not reported. It was reported that patient had 1st vaccine the previous day afternoon. This morning on 25Feb2021 at about 9:30 AM, the patient felt faint and his defibrillator went off. Has a follow up with cardiology tomorrow. It was reported that event took place after use of product. The outcome of event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823857
Sex: M
Age:
State: IL

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210303; Test Name: body temperature; Result Unstructured Data: Test Result:increased

Allergies:

Symptom List: Unevaluable event

Symptoms: Overall slight fatigue; increased body temperature; unable to lift my arm; Extreme soreness in left arm centered on injection site; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 25-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 02Mar2021 at 10:00 (at the age of 25-year-old) as single dose for COVID-19 immunisation. The patient's medical history included Childhood Pneumonia (caused slight damage to lungs, Body temperature fluctuations common due to medication). The patient's concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication. The patient previously took penicillin B for drug hypersensitivity and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Mar2021 at 10:00, the patient experienced extreme soreness in left arm centered on injection site, unable to lift my arm. On 03Mar2021 the patient experienced overall slight fatigue, increased body temperature. It was reported that light soreness began within 30 minutes after injection and increased gradually throughout the day on March 2nd 2021. Extreme soreness to the point of being unable to lift my arm the following day caused me to miss work. These symptoms regressed with rest and stretching until the evening, at which point the patient was fully functional again. The other symptoms were very light and only occurred from Wednesday March 3rd to Thursday March 4th. No further symptoms have developed since. The patient underwent lab tests and procedures which included body temperature: increased on 03Mar2021. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. Patient did not receive treatment for the events. Outcome of the events fatigue, increased body temperature was recovered on 4Mar2021 and outcome of the other events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ADDERALL

Current Illness:

ID: 1823858
Sex: F
Age:
State: NE

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: sore throat; This is a spontaneous report from a contactable consumer (patient) received through. A female patient of an unspecified age received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1 SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. on an unspecified date the patient experienced sore throat. Caller schedule for second dose wants to know if it is okay to take the second dose. The event outcome was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823859
Sex: F
Age:
State: OH

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: muscle sore at the injection site; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Formulation: Solution for injection Batch/Lot number was not reported) via an unspecified route of administration on 24Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. After first dose of vaccine the patient experienced muscle sore at injection site on 25Feb2021. The outcome of the event was unknown. Information about batch/lot number is requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823860
Sex: F
Age:
State: NC

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Slight bump at site of vaccination; Quite tired.; This is a spontaneous report from a contactable consumer. This 70 Years Old female consumer reported. A 70-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 11:00 (at the age of 70-years-old) as a single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included multiple sclerosis. Concomitant medication(s) in two weeks included venlafaxine (VENLAFAXINE) taken for multiple sclerosis. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 (at the age of 70-years-old) as a single dose for covid-19 immunization. The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced slight bump at site of vaccination, quite tired on an unspecified date. The patient did not receive any treatment. Outcome of the event was recovered, at the time of this report. Information about lot/batch number has been requested. Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021239805 similar report from same reporter

Other Meds: VENLAFAXINE

Current Illness:

ID: 1823861
Sex: F
Age:
State: CO

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer or other non-health care professional (patient) via Pfizer-sponsored program Support. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (batch or lot number was not reported) as dose 1, single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sinus drainage, sore throat. It was reported that she scheduled for second shot this morning was not able to take it because she has some sinus drainage and sore throat but still confirming if she can take it. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823862
Sex: F
Age:
State: NM

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Light sensitivity; Swollen arm; Achy body; This is a spontaneous report from a contactable consumer (Patient herself). A 61-years-old nonpregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: dn6202), via an unspecified route of administration, administered in Arm Left on 24Feb2021 at 12:15 (at the age of 61 years old) as single dose for covid-19 immunisation. Medical history included hbp, heart murmur, slight narrowing of heart valve, anemia , arthritis, osteopenia, cutaneous lupus, allergies, uterine fibroids and known_allergies: sulfites in food from an unknown date and unknown if ongoing, The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot Number: em9810), via an unspecified route of administration, administered in Arm Left on 03Feb2021 at 12:15 as dose 1, single for COVID-19 immunisation and recived flonase and experienced known allergies. The patient had no other vaccine in four weeks. It was reported that patient took concomitant medications in two weeks. On 25Feb2021 at 08:00, the patient experienced light sensitivity, swollen arm, achy body. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of light sensitivity, swollen arm, achy body was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1823863
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer. A female patient, of an unspecified age, received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, in left arm, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unknown date, the reporter read an article dated Jan 12, 2021 about a woman who had "uncontrollable shaking and tongue spasms" after receiving the vaccine. It was called "some kind of conversion thing to do with the nervous system." The reporter stated she read the woman also received her injection in the same arm as she did. Reporter would like to know if tingling and muscle spasms are a side effect of the vaccine. The reporter was concerned because in her research she has not seen a breakdown of any specific adverse events occurring with specific ethnicities. The outcome of events reported unknown for all. No follow-up attempts possible. Information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823864
Sex: F
Age:
State: NC

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: I have pain in my upper back radiating up the right side of my neck and down my right arm.; I have pain in my upper back radiating up the right side of my neck and down my right arm.; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown (Not available/not provided to reporter at the time of report completion)) via an unspecified route of administration, administered in Arm Left on 27Feb2021 at 10:15 (Age at Vaccination: 38-year-old) as dose 1, single for covid-19 immunization at workplace clinic. The patient took no other vaccine in four weeks, had not covid prior vaccination and was not covid tested post vaccination. Medical history included obese and overweight. The patients known allergy was codeine Patient took other medications (unspecified) in two weeks. On 28Feb2021 at 03:00, the patient stated that she had pain in her upper back radiating up the right side of her neck and down her right arm. It was unknown if the treatment for adverse events was taken by the patient. The outcome of event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823865
Sex: F
Age:
State: MA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: left hand pinky finger and ring finger tingling and ache/pain all day; left hand pinky finger and ring finger tingling and ache/pain all day; site injection and shoulder pain in left arm; This is a spontaneous case received from a contactable consumer (patient herself). A 42-year-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247, Expiration date: May2021), via an unspecified route of administration, administered on 02Mar2021 as DOSE 1, SINGLE (age at vaccination 42-year-old) for COVID-19 immunization. The patient medical history included allergies to steroids, allergy/contact dermatitis from latex, allergy/sensitivity to dairy, diagnosed with eczema in teens and with IBS (irritable bowel syndrome) in 2018. Concomitant medications were reported as none. On 02Mar2021, the patient experienced site injection and shoulder pain in left arm. On 03Mar2021, the patient experienced left hand pinky finger and ring finger tingling and ache/pain all day. The outcome of the event on was recovering (04Mar2021 symptoms subsiding). No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1823866
Sex: F
Age:
State: WI

Vax Date: 02/17/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: has red spot the size of a baseball at the injection site; This is a spontaneous report from a contactable consumer from a Pfizer sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 17Feb2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced has red spot the size of a baseball at the injection site on an unspecified date in Feb2021. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1823867
Sex: M
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report from a contactable Physician (patient) reporting for himself. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6203), intramuscularly, administered in Left arm on 25Feb2021 14:45 at the age of 56-years-old as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were none. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9809), intramuscularly, administered in Left arm on 04Feb2021 15:45 at the age of 56-years-old as single dose for covid-19 immunisation. Relevant tests were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 25Feb2021 at 20:00, the patient experienced arm soreness, headache and fatigue. No treatment was received for adverse events. Seriousness criteria for events was reported as non-serious. The outcome of events was recovered on an unspecified date in 2021. No follow attempts are possible; No further information is expected.

Other Meds:

Current Illness:

ID: 1823868
Sex: U
Age:
State: LA

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Muscle pains in right arm, both of my sides, right above the breast lining; Body ache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6200) via an unspecified route of administration on 25Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. On an unspecified date, patient experienced side effects like the muscle pains in right arm, both of sides, right on the sides, right above the breast lining, sometimes get it in the back, in the back it comes and goes but this was higher on the sides and had the body aches. Patient was just wondering what is the length of time of recovery or how would it go. Outcome of the events was unknown at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1823869
Sex: M
Age:
State: NJ

Vax Date: 02/28/2021
Onset Date: 02/20/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: This is spontaneous report received from a contactable consumer. This consumer (other non-HCP) reported for 48-year-old male patient that who received bnt162b2 (BNT162B2) solution for injection, dose 2 (Batch/Lot Number: EN6203) via an unspecified route of administration in arm left on 28Feb2021 08:00 (at the age of 48-years-old) as dose 2 single for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. No seriousness criteria results in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Disabling/Incapacitating, Congenital anomaly/birth defect. Historical Vaccine dose 1 BNT162B2 (Lot number=EM9809) via unspecified route of administration on 07Feb2021 08:30 AM as a dose 1 single for COVID-19 immunisation. The patient reported the symptoms to me when he started experiencing the symptoms on Sunday night, Feb28th (on 28Feb2021 22:00) and also when they worsened by Monday, Mar1. He is still experiencing some fatigue, and dizziness/light-headedness today, but says symptoms have improved. On 01Mar2021 we received a safety report from you for a patient named (initial) about experiencing some adverse event after COVID-19 vaccination. As the awareness date sometimes is not specified in the reporting system; he is asking could you please confirm on which date you became aware of the events and. who provided the first-hand knowledge of the events to you. This will help with the processing of Pfizer safety report and follow up activities. Please refer to the report in attachment for more information. Thanks in advance. Outcome off the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823870
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: light muscle and bone aches; light muscle and bone aches; felt like taking naps for a week; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced light muscle and bone aches and felt like taking naps for a week. It was unknown if patient was diagnosed with COVID-19 prior to vaccination and had been tested for COVID-19 since the vaccination. The outcome of the events was unknown. No follow-up attempts were needed, information about lot/batch number could not be obtained.

Other Meds:

Current Illness:

ID: 1823871
Sex: M
Age:
State: CA

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Anxiety; pain from top back of his head to bottom of neck; pain from top back of his head to bottom of neck; This is a spontaneous report from a contactable consumer (Patient) or other non HCP. A 71-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9266, expiration date: May2021), via an unspecified route of administration in arm left on 22Feb2021 (at the age of 71-years-old) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. Historical vaccine included the first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration on an unspecified anatomical location on unspecified date as dose 1, single for covid-19 immunisation. On an unknown date, the patient experienced anxiety. on 23Sep2021, after 1 day vaccination the patient experienced pain from top back of his head to bottom of neck. Consumer reported that he had some effects after he had his last shot which he got last on the 22Feb. He says that the day after he had reaction to it where the top of the back of his head to the bottom of his neck felt like someone hit him like something real hard. He said that the second dose also altered his nerves, meaning anxiety, quite a bit. He said that he did not have the pain to the top of his head down to the bottom of his neck before getting the second dose, it was new. Patient received treatment for event back of his head down to the bottom of his neck pain for treatment Tylenol two to three days after that. The outcome of events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823872
Sex: F
Age:
State: CO

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: experienced stiffness and body ache after the 1st dose and the caller mentioned that he also experienced the same thing yesterday; experienced stiffness and body ache after the 1st dose; This is a spontaneous report from a contactable consumer reporting for a patient (wife) received from a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter stated that on an unspecified date, his wife has experienced stiffness and body ache after the 1st dose and the reporter asked if his wife can take a Tylenol. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1823873
Sex: M
Age:
State: MI

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Sore soft tissue around injection site for about 18 hours after injection; This is a spontaneous report from a contactable consumer or other non hcp. A 47-years-old male patient received bnt162b2 (BNT162B2(PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: EL3248), dose 1 via an unspecified route of administration, administered in Arm Left on 02Mar2021 07:30 as SINGLE DOSE for covid-19 immunisation. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. Medical history included gout, nephrolithiasis. Concomitant medication(s) included multivitamins (MULTIVITAMINS; probiotics (PROBIOTICS); cholecalciferol, ubidecarenone (COQ10 + D3); fish oil (FISH OIL); ergocalciferol (VIT D). It was Reported that, the patient experienced sore soft tissue around injection site for about 18 hours after injection on 02Mar2021 with outcome of recovered. Follow-up (10Mar2021): This is a follow-up spontaneous report in response to mail trail sent regarding the confirmation of below mentioned query. This reported included Follow-up (11Mar2021): This is a follow-up spontaneous report in response to mail trail sent regarding the confirmation of below mentioned query. This reported included that. No follow-up attempts are needed. No further information is expected.

Other Meds: Multivitamins; PROBIOTICS; COQ10 + D3; FISH OIL; VIT D

Current Illness:

ID: 1823874
Sex: F
Age:
State: FL

Vax Date: 02/14/2021
Onset Date: 02/17/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: rash on her injection arm; This is a spontaneous report from a Pfizer-sponsored program with Regulatory Authority SUPPORT via contactable consumer or other non HCP (Patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 formulation; Solution for injection), dose 1 via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced rash on her injection arm on 17Feb2021 (three days later after vaccination). It was reported that symptoms went away in 2-3 days. The outcome of event reported as recovered (went away in 2-3 days) on an unknown date of Feb2021. Follow-up attempts completed. No further information expected, information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823875
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose 2, single for COVID-19 immunization. Medical history included psoriasis (Patient had chronically Psoriatic spots on leg for years, the size of the spot was 1 square centimetre). The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose 1, single for COVID-19 immunization. On an unspecified date, three weeks after 2nd Pfizer vaccine, the spot disappeared & the skin has healed itself. Intuitively patient think it is dues to the vaccine raising immune system level. The outcome of the event was unknown. No follow-up attempts are needed. Information about Lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1823876
Sex: F
Age:
State: NJ

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: felt like a node like where the earring would be; on the back of her ear like a lump; it was burning and hot; it was burning and hot; it stings; Nausea; Lightheadedness; bruise; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration, administered in Arm Right on 18Feb2021 18:00 (at the age of 54 years old) as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. No history of any previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. Adverse event did not require a visit to Emergency Room/Physician Office. No vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. No Adverse events following prior vaccinations. No relevant medical history (including any illness at time of vaccination). No relevant family medical history to adverse event. No relevant tests done. On 19Feb2021, the patient experienced felt like a node like where the earring would be, on the back of her ear like a lump, it was burning and hot, it stings, Nausea, Lightheadedness, and bruise. She thought it was from her glasses and she was putting Neosporin and Vaseline on it. She asked if it was a coincidence or was it from the vaccine? She said that it was a lot better. It was burning and it stung just on that one ear. It had gone down tremendously though. It was black and blue where her glasses touched. The heat was around the top of the ear. She clarified that it was her left ear. The swelling went down, and she did not really feel it yesterday, but she felt it today. She said that it started to bother her again after she had her haircut. She said that it was like a throbbing on her ear. She said that before she could not even keep her glasses on because it was bothering her. She said that she thought her ear was irritated from her haircut last night. She still went to work, and it was not so bad that she could not handle it. She said that she had her energy back as of yesterday. Her second dose is scheduled for the 18Mar2021. Therapeutic measures were taken as a result of felt like a node like where the earring would be, on the back of her ear like a lump, it was burning and hot. The outcome of the events felt like a node like where the earring would be, on the back of her ear like a lump, Nausea, Lightheadedness were recovered on 04Mar2021; and other events it was burning and hot, it stings, Nausea, bruise were recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823877
Sex: F
Age:
State: AL

Vax Date: 02/19/2021
Onset Date: 02/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:degenerative or bulging disc; Comments: Verbatim:degenerative or bulging disc; Test Name: X-ray; Result Unstructured Data: Test Result:degenerative or bulging disc; Comments: verbatim:degenerative or bulging disc.

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: got her first dose on 19Feb2021. She had her epidural injection for her degenerative disks on 23Feb2021; This is a spontaneous report from a Pfizer Sponsored program Support. A female consumer reported for herself that a 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6200), via an unspecified route of administration in left arm on 19Feb2021 (at the age of 59 years old) as dose 1, single for covid-19 immunisation. Medical history included seizure from 1991 to an unknown date, pain and swelling from degenerative disc, anxiety from an unknown date and unknown if ongoing, hormone level abnormal from an unknown date and unknown if ongoing, thyroid disorder from an unknown date and unknown if ongoing, rosacea from an unknown date and unknown if ongoing. The patient had known allergies. Concomitant medications included carbamazepine (TEGRETOL) 200 mg three times daily, for seizure from 1995 and ongoing; zonisamide (ZONEGRAN) 100 mg, four by mouth daily for seizure from 2020 and ongoing; escitalopram oxalate (LEXAPRO) 20 mg daily for anxiety, seizure from 2018 and ongoing; levocetirizine, 5 mg daily for allergies from 2011 and ongoing; progesterone, 100 mg daily for hormone level abnormal from 2011 and ongoing; levothyroxine, 10 mg daily for thyroid disorder from 2016 and ongoing; doxycycline, 100 mg daily for rosacea from 2019 and ongoing. The patient did not receive any other vaccines within 4 weeks. The patient did not have history of all previous immunization with the Pfizer vaccine considered as suspect. The patient did not receive additional vaccines on same date of the Pfizer suspect. They kept switching her seizure medication initially. The patient got her first dose on 19Feb2021. She had her epidural injection for her degenerative disks on 23Feb2021. The patient had an epidural with steroids after getting the Covid-19 vaccine. She wanted to confirm if she did something wrong taking her epidural injection after her first dose of the vaccine. She had been having pain. She had a MRI and an X-ray. She has a degenerative or bulging disc. They gave her a steroid to help with the pain and swelling. She read that you should not have steroid injections within 2 periods of getting the vaccine. She was worried that this affected the vaccine. The patient underwent lab tests and procedures which included magnetic resonance imaging: degenerative or bulging disc or degenerative, x-ray: degenerative or bulging disc. The patient did not visit emergency room or physician office. The outcome of event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: TEGRETOL; ZONEGRAN; LEXAPRO; LEVOCETIRIZINE; PROGESTERONE; LEVOTHYROXINE; DOXYCYCLINE.

Current Illness:

ID: 1823878
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: This is a spontaneous report from a contactable retired nurse (patient). A 66-years-old female patient received bnt162b2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number: not reported) via an unspecified route of administration on 26Feb2021 as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, after receiving the first dose the patient had a typical reaction, elevated, red circle and warm to the touch. It was about 2 inches in diameter. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823879
Sex: F
Age:
State: OR

Vax Date: 12/30/2020
Onset Date: 01/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: increased bilateral tinnitus; sensation of aural fullness/increased aural fullness; sensation of aural fullness/increased aural fullness; This is a spontaneous report from a contactable physician (Patient) reported in response to HCP letter sent in a cross-reference case which included that. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EK9231, Expiry date was not reported), via intramuscular route of administration on 30Dec2020 08:30 (age at the time of vaccination was 58-year-old) in Deltoid Left as dose 1, single for COVID-19 immunization. The Patient's medical history included rhinitis allergic from an unknown date and unknown if ongoing, pain from an unknown date and unknown if ongoing. Concomitant medication(s) included loratadine (LORATADINE) taken 10 mg daily as needed for rhinitis allergic, start and stop date were not reported; paracetamol (TYLENOL) taken 500-1000 mg once a day as needed for pain, start and stop date were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior vaccination (within 4 weeks) was not applicable and AE following prior vaccinations was none. Family Medical History Relevant to AE was not applicable. On 01Jan2021 08:00, the patient experienced increased bilateral tinnitus, sensation of aural fullness/increased aural fullness (ear discomfort), sensation of aural fullness/increased aural fullness (condition aggravated), mild-moderate, lasting several days. Causal Relationship was there a reasonable possibility that the event is related to suspect products yes. The patient was not visited to emergency room. The patient visited physician office and received treatments for the events. The outcome for the event increased bilateral tinnitus was not recovered and event sensation of aural fullness/increased aural fullness (ear discomfort) was unknown and event sensation of aural fullness/increased aural fullness (condition aggravated) was recovered on 06Jan2021. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds: LORATADINE; TYLENOL

Current Illness:

ID: 1823880
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: chills; headache; This is a spontaneous report from a contactable Other HCP via Pfizer Sales Representative. This Other HCP reported for a patient of unknown age and gender who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and experienced headache and chills. On an unknown date the patient experience chills and headache. The event outcome was unknown. No follow-up attempts were possible; information about lot/batch number could not be obtained.

Other Meds:

Current Illness:

ID: 1823881
Sex: F
Age:
State: RI

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Mild pain at injection site; Being sleepy at that time; This is a spontaneous report received from a contactable consumer (patient). A 60-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration in arm left on 01Mar2021 11:00 AM (Lot Number: EL3247, age at vaccination 60-year-old) as dose 1, single for COVID-19 immunization. Medical history was none. Patient received other medications (unspecified) within 2 weeks of vaccination. On 01Mar2021 23:00, the patient experienced mild pain at injection site approximately 12 hours after vaccination duration (approx 14 hours). It was reported that late at night on 01Mar2021, started to notice very mild soreness that started about 11 PM in the evening (12 hours after vaccination), and being sleepy at that time. She did not report the event until the next day (02Mar2021). No treatment received for the adverse event mild pain at injection site. No information on the treatment received for being sleepy at that time was reported. It was reported that facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination was the patient was not diagnosed with COVID-19. Since the vaccination has the patient has been tested for COVID-19. No allergies to medications food or other products. The patient was not pregnant at the time of the vaccination. The event mild pain at injection site recovered on 02Mar2021 13:00 while the outcome of the event being sleepy at that time was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823882
Sex: U
Age:
State: PA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Flu-like symptoms but did not get the Flu; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for a patient. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was unknown), via an unspecified route of administration on an unspecified date in Feb2021 at dose number unknown, single for covid-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient has been tested for COVID-19, since the vaccination. On an unspecified date in Feb2021 the patient experienced flu-like symptoms but did not get the flu. It was unknown whether the patient received treatment for the adverse event. You have reported about an adverse regarding covid-19 vaccine, please help the first awareness date of this event. You filled as 02Mar2021, however the adverse event start date Feb2021, could you please help confirm the first awareness date when you knew about the events. Please also help confirm who told the events to you or how do you knew about it. Outcome of the event was unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823883
Sex: M
Age:
State: NY

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Slight pressure in head; This is a spontaneous report from a contactable consumer or other non-health care professional reported for a male patient. A 32-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, in left arm on 26Feb2021 (at the age of 32-years-old) as dose 1, single for covid-19 immunization. The patient medical history included asthma. Concomitant medications were not reported. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 27Feb2021, the patient experienced slight pressure in head. Therapeutic measures were taken as a result of the event and treatment included Tylenol. Outcome of the event was recovered unspecified date 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823884
Sex: F
Age:
State: MA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Muscle pain in arm at injection site; This is spontaneous report received from a contactable consumer. A 24-year-old non pregnant female consumer (patient) reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: el3247) via an unspecified route of administration on 01Mar2021 at 02:15 PM (at 24-year-old) on left arm as dose 1, single for COVID-19 immunization. The patient's medical history and allergies to medications, food, or other products were reported as none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, did not have covid prior vaccination and was not tested for covid post vaccination. On 01Mar2021 at 09:00 PM the patient experienced muscle pain in arm at injection site. No treatment was received for event. The patient was recovering No follow-up attempts were needed. No further information was expected.

Other Meds:

Current Illness:

ID: 1823885
Sex: F
Age:
State: PA

Vax Date: 02/21/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result: elevated.

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Loss of appetite; Dizziness; Elevated blood pressure; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration, administered in arm right on 21Feb2021 (at the age of 61-years) as dose 2, single for COVID-19 immunization. Patient relevant medical history include hypothyroidism (details unspecified). The patient concomitant medications include armour for unspecified indication from an unspecified start date. The patient had the Pfizer shot on 21Feb2021 and it was normal to had stuff at this point like loss of appetite, dizziness, elevated blood pressure, and diarrhea. When confirmed if the vaccine was Pfizer COVID 19 Vaccine, the patient stated, this was her second vaccine. The patient was informed about Pfizer Medical information department and was provided with the number. The patient had them over a week after the patient had the vaccine so that concerns her a little bit. The patient did not had that, the patient now what that was. The patient realize that but the patient did not know where the patient put the card right now. The patient know the diarrhea started on Thursday or Friday, dizziness today, blood pressure checked by the school nurse yesterday, loss of Appetite about the same time on Wednesday or Thursday something like that, the patient no idea for sure. The patient did not had any treatment for adverse event. The patient had some side effects lasted longer that what was mentioned. The patient underwent lab test: blood pressure measurement: elevated on an unspecified date. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ARMOUR THYROID.

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am